ClinicalTrials.Veeva
Menu

Find clinical trials for Acute Myeloid Leukemia (AML) in Warszawa, Mazowieckie

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Acute Myeloid Leukemia
Leukemia
Myeloid Leukemia
Myelodysplastic Syndromes
Preleukemia
Syndrome
Cancer

Acute Myeloid Leukemia (AML) trials near Warszawa, Mazowieckie, POL:

Study of Liposomal Annamycin in Combination With Cytarabine for the Treatment of Subjects With Acute Myeloid Leukemia (AML)

dose-escalation study that will determine the MTD and RP2D of L-Annamycin in combination with cytarabine for the treatment of subjects with AML...

Enrolling
Leukemia, Myeloid, Acute
Drug: Liposomal Annamycin
Drug: Cytarabine

Phase 1, Phase 2

Moleculin Biotech

Warsaw, Poland and 8 other locations

to venetoclax + azacitidine in adults recently diagnosed with AML who are unable to be treated with intensive chemotherapy.Participants will...

Active, not recruiting
Acute Myeloid Leukemia (AML)
Drug: Venetoclax
Drug: Pevonedistat

Phase 2

Takeda
Takeda

Warszawa, Mazowieckie, Poland and 56 other locations

This is a clinical study for adult patients who have recently been diagnosed with acute myeloid leukemia or AML. ...

Active, not recruiting
Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation
Acute Myeloid Leukemia (AML)
Drug: azacitidine
Drug: gilteritinib

Phase 3

Astellas
Astellas

Warszawa, Mazowieckie, Poland and 110 other locations

This study enrolled 472 participants, aged 55 or older, with a diagnosis of de novo acute myeloid leukemia (AML) ...

Active, not recruiting
Leukemia, Myeloid, Acute
Drug: Placebo
Drug: Oral Azacitidine

Phase 3

Celgene
Celgene

Warsaw, Poland and 222 other locations

when administered to adult patients with relapsed or refractory acute myeloid leukemia (AML) or relapsed or progr...

Enrolling
Acute Myeloid Leukemia (AML)
High-risk Myelodysplastic Syndrome
Drug: RVU120

Phase 2

Ryvu Therapeutics

Warszawa, Mazowieckie Województwo, Poland and 24 other locations

Locations recently updated

The purpose of this extension study is to provide venetoclax and obtain long-term safety data for subjects who continue to tolerate and derive benefi...

Active, not recruiting
Acute Lymphoblastic Leukemia
Chronic Lymphocytic Leukemia
Drug: Venetoclax

Phase 3

AbbVie
AbbVie

Warszawa, Mazowieckie, Poland and 55 other locations

The purpose of the study is to characterize safety and tolerability of cusatuzumab in combination with various therapies used to treat acute ...

Active, not recruiting
Leukemia, Myeloid, Acute
Drug: Venetoclax
Drug: Cusatuzumab

Phase 1

OncoVerity

Warszawa, Poland and 22 other locations

This first-in-human study will evaluate RVU120 (SEL120), a novel small molecule CDK8/19 inhibitor, in patients with Acute Myeloid L...

Active, not recruiting
Acute Myeloid Leukemia
High-risk Myelodysplastic Syndrome
Drug: RVU120(SEL120)

Phase 1

Ryvu Therapeutics

Warsaw, Poland and 9 other locations

administered in combination with venetoclax to adult patients with acute myeloid leukemia (AML) who are relapsed ...

Enrolling
Acute Myeloid Leukemia
Drug: Venetoclax
Drug: RVU120

Phase 2

Ryvu Therapeutics

Warszawa, Mazowieckie Województwo, Poland and 35 other locations

available therapy (BAT) on overall survival (OS) in subjects with acute myeloid leukemia (AML) who are in second ...

Active, not recruiting
Acute Myeloid Leukemia
Biological: Galinpepimut-S
Drug: Azacitidine

Phase 3

Sellas Life Sciences

Warsaw, Poland and 72 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems